Hovione

Activities: Manufacturing

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Using clinical data to drive effective formulation optimisation Conventional approaches to develop and optimise formulations are suboptimal and require extensive pharmaceutical development activities to be undertaken prior to clinical...
  2. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  3. Gerresheimer cooperates with Injecto and launches silicone-oil- and PFAS-free syringe systems Supply and license agreement with Injecto Group for long-term availability of silicone-oil-free plunger stoppers; avoiding silicone-oil significantly reduces particle pollution
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Tariff hikes call for CPOs to keep reputational issues and costs down Time for procurement in the pharmaceutical industry to tap into internal expertise
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Improving ADC selection with AI-enabled assays In this article, Dr Rob Monroe, Chief Medical Officer at Leica Biosystems, discusses how diagnostics companies are working with researchers to develop novel assays leveraging...

Upcoming event

Making Pharmaceuticals

29-30 April 2025 | Conference | Coventry, UK See all

Related Content

Manufacturing

Hovione to open Seixal manufacturing site in mid 2027

The $200m Portuguese site will produce particle engineering technologies and final dosage forms, and will further expand the CDMOs European manufacturing presence
Manufacturing

Hovione nearly doubles pharmaceutical spray drying capabilities at Cork, Ireland facility

The CDMO's multi-million investment will allow it to significantly increase its spray drying capacity, which is necessary for inhaled and oral therapeutics
Research & Development

Hovione and Zerion Pharma create joint venture to further expand the use of Dispersome technology

Hovione Farmaciência and Zerion Pharma have expanded their partnership to accelerate the development of the Dispersome technology platform and further expand its applicability and reach for increasing the solubility and bioavailability of small drug molecules
Manufacturing

Hovione debuts novel continuous tableting line in Lisbon R&D centre

The continuous tableting line will process high potency active pharmaceutical ingredients (APIs)
Manufacturing

Hovione and GEA partner to advance continuous tableting technology

The collaboration will aim to bring continuous tableting to the same level of maturity as batch tableting
Research & Development

Hovione and Dragonfly Technologies offer sustainable micellar chemistry as an alternative to conventional processes

The agreement provides Hovione with the capability to develop chemistry-in-water, enabling a significant reduction in carbon footprint compared with conventional chemical processes relying on traditional organic solvents
Drug Delivery

Hovione expands nasal drug delivery capabilities

In collaboration with IDC, the nasal powder delivery device technology provides a good alternative to conventional delivery routes for both local and systemic drug delivery
Subscribe now